FRANKFURT: German chemicals and pharmaceuticals giant Bayer said Monday it has agreed to buy US women’s healthcare specialist Conceptus for $1.1 billion (852 million euros).
“Bayer intends to broaden its portfolio in the field of contraception. Bayer HealthCare LLC has therefore signed a merger agreement with Conceptus, Inc.,” Bayer said in a statement.
California-based Conceptus developed the Essure procedure, a non-surgical permanent birth control method.
“With this acquisition, Bayer will be able to offer a complete range of short-term, long-term and permanent contraceptive choices for women,” the German company said.
Bayer would launch a public tender offer “within the next ten business days to acquire all shares in Conceptus.”
It said the transaction valued Conceptus at “approximately $1.1 billion or 852 million euros, representing $31.00 per share in cash.”
The deal was subject to anti-trust approval in the US and was expected by mid 2013, Bayer said.
Dear TNT Reader,
At The News Tribe, our mission is to bring you free, independent, and unbiased news and content that keeps you informed and empowered. We are committed to upholding the highest standards of journalism, as we understand that we are a platform for truth.
Apart from independent global news coverage, we also commit our unique focus on the Muslim world. In an age marked by the troubling rise of Islamophobia and widespread misrepresentation of Muslims in Western media, we strive to provide accurate and fair coverage.
But to continue doing so, we need your support. Even a small donation of 1$ can make a big difference. Your contribution will help us maintain the quality of our news and counteract the negative narratives that are so prevalent.
Please consider donating today to ensure we can keep delivering the news that matters. Together, we can make a positive impact on the world, and work towards a more inclusive, informed global society.
Donate Monthly Subscription Annual Subscription